These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29788886)

  • 1. Novel Pharmacotherapeutic Approaches in Treatment of Alcohol Addiction.
    Pakri Mohamed RM; Kumar J; Ahmad SU; Mohamed IN
    Curr Drug Targets; 2018; 19(12):1378-1390. PubMed ID: 29788886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in Pharmacotherapy of Alcoholism.
    Soyka M; Lieb M
    Pharmacopsychiatry; 2015 Jul; 48(4-5):123-35. PubMed ID: 25761458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.
    Burnette EM; Nieto SJ; Grodin EN; Meredith LR; Hurley B; Miotto K; Gillis AJ; Ray LA
    Drugs; 2022 Feb; 82(3):251-274. PubMed ID: 35133639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment of alcohol use disorder. Scientific evidence.
    Attilia F; Perciballi R; Rotondo C; Capriglione I; Iannuzzi S; Attilia ML; Vitali M; Alessandrini G; Scamporrino MCM; Fiore M; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):123-127. PubMed ID: 29912214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nalmefene (Selincro) orally].
    J Pharm Belg; 2014 Dec; (4):51-2. PubMed ID: 25562928
    [No Abstract]   [Full Text] [Related]  

  • 6. Dispensing of medication for alcohol use disorder; an examination of large databases in a New Zealand context.
    Beaglehole B; Foulds J; Mulder RT; Boden JM
    N Z Med J; 2019 May; 132(1495):48-53. PubMed ID: 31095544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of pharmacotherapy for the treatment of alcohol dependence.
    Garbutt JC
    J Subst Abuse Treat; 2009 Jan; 36(1):S15-23; quiz S24-5. PubMed ID: 19062347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hospitalisation and death related to baclofen for alcohol use disorders: Comparison with nalmefene, acamprosate, and naltrexone in a cohort study of 165 334 patients between 2009 and 2015 in France.
    Chaignot C; Zureik M; Rey G; Dray-Spira R; Coste J; Weill A
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1239-1248. PubMed ID: 30251424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol dependence: after the withdrawal phase. Long-term abstinence: better health and psychosocial status. Psychosocial support for a chronic disorder. Some drugs are useful adjuncts to medical support.
    Prescrire Int; 2009 Oct; 18(103):222-3. PubMed ID: 19882797
    [No Abstract]   [Full Text] [Related]  

  • 10. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Baclofen: when does one know the scientific truth about its effectiveness in alcoholic disease?].
    Nau JY
    Rev Med Suisse; 2015 Sep; 11(485):1674-5. PubMed ID: 26540999
    [No Abstract]   [Full Text] [Related]  

  • 12. Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
    Castrén S; Mäkelä N; Alho H
    Curr Opin Psychiatry; 2019 Jul; 32(4):266-274. PubMed ID: 30973369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
    Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
    J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug adjuncts for treating alcohol dependence.
    Collins GB; McAllister MS; Adury K
    Cleve Clin J Med; 2006 Jul; 73(7):641-4, 647-8, 650-1, passim. PubMed ID: 16845975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacotherapies and personalized medicine for alcohol use disorder: a review.
    Lohoff FW
    Pharmacogenomics; 2020 Oct; 21(15):1117-1138. PubMed ID: 32807012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in the pharmacotherapy of alcoholism.
    Myrick H; Anton R
    Curr Psychiatry Rep; 2004 Oct; 6(5):332-8. PubMed ID: 15355755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging pharmacotherapies for alcohol dependence: a systematic review focusing on reduction in consumption.
    Aubin HJ; Daeppen JB
    Drug Alcohol Depend; 2013 Nov; 133(1):15-29. PubMed ID: 23746430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy of alcoholism - an update on approved and off-label medications.
    Soyka M; Müller CA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1187-1199. PubMed ID: 28658981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapies for alcoholism: the old and the new.
    Olive MF
    CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):2-4. PubMed ID: 20232494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naltrexone-Associated Acute Pancreatitis.
    Verma R
    Prim Care Companion CNS Disord; 2016 Nov; 18(6):. PubMed ID: 27922226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.